July/August 2018—NOVARTIS PLANS TO SPIN OFF ALCON
Novartis plans to spin off its eye care devices division, Alcon, into a separately traded standalone company, the company announced in June…
David S. Boyer, MD
July/August 2018—The cornea and sclera stand in the way of this more convenient, less invasive drug delivery modality.
Glenn J. Jaffe, MD
July/August 2018—An injectable sustained drug delivery system may have advantages over existing options.
An interview with Carl D. Regillo, MD
July/August 2018—A principal investigator for a surgically implanted port delivery system talks about the device’s design and performance in patients with wet AMD.
May/June 2018—Ablate-and-Replace Gene Therapy Was Successful in Mouse Model of RP
An approach to gene therapy in which a gene editing tool is used to delete a mutated gene and replace it…
Thomas Ciulla, MD, MBA
March 2018—Gene therapy offers promise but poses a challenge to current payment models.
Pravin U. Dugel, MD
March 2018—Next-generation anti–VEGF-A drugs and combination agents show potential.
October 2017—NEI Award for ‘Retina in a Dish’
A team at the University of Maryland received a $90,000 award from the US National Eye Institute (NEI) for its proposal to crea…
